The present invention relates to covalently cross-linked glycosylated mucin nanoparticles and the use thereof for the delivery and release of active ingredients, markers and/or biomolecules. The subject matter of the invention also relates to covalently cross-linked glycosylated mucin nanoparticles comprising at least one compound selected from an active ingredient, a marker and a biomolecule. The invention further relates to a method for preparing covalently cross-linked glycosylated mucin nanoparticles, optionally comprising at least one compound selected from an active ingredient, a marker and a biomolecule.
COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES
P. Petrini;
2021-01-01
Abstract
The present invention relates to covalently cross-linked glycosylated mucin nanoparticles and the use thereof for the delivery and release of active ingredients, markers and/or biomolecules. The subject matter of the invention also relates to covalently cross-linked glycosylated mucin nanoparticles comprising at least one compound selected from an active ingredient, a marker and a biomolecule. The invention further relates to a method for preparing covalently cross-linked glycosylated mucin nanoparticles, optionally comprising at least one compound selected from an active ingredient, a marker and a biomolecule.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
WO2021260525A2.pdf
accesso aperto
Descrizione: Testo domanda di brevetto PCT
:
Publisher’s version
Dimensione
16.87 MB
Formato
Adobe PDF
|
16.87 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
